A New Family of Small Molecules To Probe the Reactivation of Mutant p53
摘要:
Cells that express mutant p53 derived from cancers are selectively killed by a new class of small organic molecules. The protein p53 is recognized as one of the most important guardians in the body that prevents tumor development. Mutant forms of p53 are present in approximately 50% of all human cancers. Molecules that selectively kill cells expressing mutant p53 could become important chemotherapeutic agents. Our research focuses on developing a synthetically accessible class of molecules that can be easily modified to examine structural activity relationships and mechanism of biological activity or to optimize for anticancer activity. In this communication, a new class of molecules that selectively arrests growth of cells expressing two forms of mutant p53 is described. Synthetic routes to these compounds are also presented.
Compounds and Related Methods for Mutant p53 Reactivation
申请人:Appella Daniel H.
公开号:US20080206805A1
公开(公告)日:2008-08-28
Ketoamine compounds and related methods for reactivation of tumor suppressor protein p53.
Ketoamine化合物及其相关方法,用于重新激活肿瘤抑制蛋白p53。
[EN] COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION<br/>[FR] COMPOSES ET PROCEDES ASSOCIES POUR UNE REACTIVATION DE P53 MUTANTE
申请人:UNIV NORTHWESTERN
公开号:WO2005042481A3
公开(公告)日:2005-08-25
US7329775B2
申请人:——
公开号:US7329775B2
公开(公告)日:2008-02-12
US7829304B2
申请人:——
公开号:US7829304B2
公开(公告)日:2010-11-09
A New Family of Small Molecules To Probe the Reactivation of Mutant p53
作者:Michael C. Myers、Wang、Jaclyn A. Iera、Jeong-kyu Bang、Toshiaki Hara、Shin'ichi Saito、Gerard P. Zambetti、Daniel H. Appella
DOI:10.1021/ja045752y
日期:2005.5.1
Cells that express mutant p53 derived from cancers are selectively killed by a new class of small organic molecules. The protein p53 is recognized as one of the most important guardians in the body that prevents tumor development. Mutant forms of p53 are present in approximately 50% of all human cancers. Molecules that selectively kill cells expressing mutant p53 could become important chemotherapeutic agents. Our research focuses on developing a synthetically accessible class of molecules that can be easily modified to examine structural activity relationships and mechanism of biological activity or to optimize for anticancer activity. In this communication, a new class of molecules that selectively arrests growth of cells expressing two forms of mutant p53 is described. Synthetic routes to these compounds are also presented.